Literature DB >> 11696569

Is it time to modify the reverse cholesterol transport model?

A R Tall1, N Wang, P Mucksavage.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11696569      PMCID： PMC209451          DOI： 10.1172/JCI14342

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  23 in total

Review 1.  Tangier disease as a test of the reverse cholesterol transport hypothesis.

Authors:  A R Tall; N Wang
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

2.  'Orphans' meet cholesterol.

Authors:  A R Tall; P Costet; Y Luo
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

3.  Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor.

Authors:  P Costet; Y Luo; N Wang; A R Tall
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

4.  Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile.

Authors:  Y Ji; N Wang; R Ramakrishnan; E Sehayek; D Huszar; J L Breslow; A R Tall
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

5.  Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice.

Authors:  P Mardones; V Quiñones; L Amigo; M Moreno; J F Miquel; M Schwarz; H E Miettinen; B Trigatti; M Krieger; S VanPatten; D E Cohen; A Rigotti
Journal:  J Lipid Res       Date:  2001-02       Impact factor: 5.922

6.  Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1.

Authors:  N Wang; D L Silver; P Costet; A R Tall
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

7.  Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.

Authors:  J J Repa; S D Turley; J A Lobaccaro; J Medina; L Li; K Lustig; B Shan; R A Heyman; J M Dietschy; D J Mangelsdorf
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

8.  Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.

Authors:  S M Clee; J J Kastelein; M van Dam; M Marcil; K Roomp; K Y Zwarts; J A Collins; R Roelants; N Tamasawa; T Stulc; T Suda; R Ceska; B Boucher; C Rondeau; C DeSouich; A Brooks-Wilson; H O Molhuizen; J Frohlich; J Genest; M R Hayden
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

9.  High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1.

Authors:  J McNeish; R J Aiello; D Guyot; T Turi; C Gabel; C Aldinger; K L Hoppe; M L Roach; L J Royer; J de Wet; C Broccardo; G Chimini; O L Francone
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

10.  Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus.

Authors:  I Shimomura; Y Bashmakov; J D Horton
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157
View more
  14 in total

Review 1.  A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta.

Authors:  Sean Ekins; Leonid Mirny; Erin G Schuetz
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

2.  Conway Memorial Lecture 2002. The dyslipidaemia of diabetes: lessons in the pathogenesis of atherosclerosis.

Authors:  G H Tomkin
Journal:  Ir J Med Sci       Date:  2002 Oct-Dec       Impact factor: 1.568

3.  Intracerebroventricular leptin regulates hepatic cholesterol metabolism.

Authors:  Sonya Vanpatten; George B Karkanias; Luciano Rossetti; David E Cohen
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

4.  A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol.

Authors:  Sandhya Sankaranarayanan; Ginny Kellner-Weibel; Margarita de la Llera-Moya; Michael C Phillips; Bela F Asztalos; Robert Bittman; George H Rothblat
Journal:  J Lipid Res       Date:  2011-09-27       Impact factor: 5.922

5.  HDL proteomics: pot of gold or Pandora's box?

Authors:  Muredach P Reilly; Alan R Tall
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

Review 6.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

Review 7.  Future therapeutic directions in reverse cholesterol transport.

Authors:  Amit V Khera; Daniel J Rader
Journal:  Curr Atheroscler Rep       Date:  2010-01       Impact factor: 5.113

Review 8.  Will torcetrapib be the next big thing in coronary heart disease risk reduction?

Authors:  James M McKenney; John A Hoekstra
Journal:  Curr Atheroscler Rep       Date:  2007-01       Impact factor: 5.113

9.  ABCA1 plays no role in the centripetal movement of cholesterol from peripheral tissues to the liver and intestine in the mouse.

Authors:  Chonglun Xie; Stephen D Turley; John M Dietschy
Journal:  J Lipid Res       Date:  2009-03-12       Impact factor: 5.922

10.  Balancing cholesterol synthesis and absorption in the gastrointestinal tract.

Authors:  David E Cohen
Journal:  J Clin Lipidol       Date:  2008-04       Impact factor: 4.766
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.